Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

PURPOSE: Anti-CD19 chimeric antigen receptors (CARs) are artificial fusion proteins that cause CD19-specific T-cell activation. Durability of remissions and incidence of long-term adverse events are critical factors determining the utility of anti-CD19 CAR T-cell therapy, but long-term follow-up of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Cappell, Kathryn M., Sherry, Richard M., Yang, James C., Goff, Stephanie L., Vanasse, Danielle A., McIntyre, Lori, Rosenberg, Steven A., Kochenderfer, James N.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2020
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655016/
https://ncbi.nlm.nih.gov/pubmed/33021872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.01467
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi